411 related articles for article (PubMed ID: 27356702)
1. High Prevalence of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Thailand.
Wanich N; Vilaichone RK; Chotivitayatarakorn P; Siramolpiwat S
Asian Pac J Cancer Prev; 2016; 17(6):2857-60. PubMed ID: 27356702
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and survival of hepatocellular carcinoma in the central region of Thailand.
Somboon K; Siramolpiwat S; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(8):3567-70. PubMed ID: 24870758
[TBL] [Abstract][Full Text] [Related]
3. Type 2 diabetes and hepatocellular carcinoma: a case-control study in patients with chronic hepatitis B.
Li Q; Li WW; Yang X; Fan WB; Yu JH; Xie SS; Liu L; Ma LX; Chen SJ; Kato N
Int J Cancer; 2012 Sep; 131(5):1197-202. PubMed ID: 22052244
[TBL] [Abstract][Full Text] [Related]
4. Hepatocellular carcinoma incidence in noncirrhotic patients with chronic hepatitis B and patients with cirrhosis of all etiologies.
Do AL; Wong CR; Nguyen LH; Nguyen VG; Trinh H; Nguyen MH
J Clin Gastroenterol; 2014 Aug; 48(7):644-9. PubMed ID: 24201999
[TBL] [Abstract][Full Text] [Related]
5. The risk of hepatocellular carcinoma within and beyond the first 5 years of entecavir in Korean patients with chronic hepatitis B.
Kim BG; Park NH; Lee SB; Jeon S; Park JH; Jung SW; Jeong ID; Bang SJ; Shin JW
Liver Int; 2018 Dec; 38(12):2269-2276. PubMed ID: 30052303
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection.
Chayanupatkul M; Omino R; Mittal S; Kramer JR; Richardson P; Thrift AP; El-Serag HB; Kanwal F
J Hepatol; 2017 Feb; 66(2):355-362. PubMed ID: 27693539
[TBL] [Abstract][Full Text] [Related]
7. Comparison between disease free survival of hepatocellular carcinoma after hepatic resection in chronic hepatitis B patients with or without cirrhosis.
Techathuvanan K; Srisajjakul S; Pongpaibul A; Limsrichamrern S; Charatcharoenwitthaya P; Chainuvati S; Tanwandee T; Chotiyaputta W
J Med Assoc Thai; 2015 Apr; 98(4):334-42. PubMed ID: 25958707
[TBL] [Abstract][Full Text] [Related]
8. Subcirrhotic liver stiffness by FibroScan correlates with lower risk of hepatocellular carcinoma in patients with HBV-related cirrhosis.
Jeon MY; Lee HW; Kim SU; Heo JY; Han S; Kim BK; Park JY; Kim DY; Ahn SH; Han KH
Hepatol Int; 2017 May; 11(3):268-276. PubMed ID: 28224351
[TBL] [Abstract][Full Text] [Related]
9. Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Papatheodoridis GV; Manolakopoulos S; Touloumi G; Vourli G; Raptopoulou-Gigi M; Vafiadis-Zoumbouli I; Vasiliadis T; Mimidis K; Gogos C; Ketikoglou I; Manesis EK;
Gut; 2011 Aug; 60(8):1109-16. PubMed ID: 21270118
[TBL] [Abstract][Full Text] [Related]
10. Liver stiffness-based optimization of hepatocellular carcinoma risk score in patients with chronic hepatitis B.
Wong GL; Chan HL; Wong CK; Leung C; Chan CY; Ho PP; Chung VC; Chan ZC; Tse YK; Chim AM; Lau TK; Wong VW
J Hepatol; 2014 Feb; 60(2):339-45. PubMed ID: 24128413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of overall survival between antiviral-induced viral suppression and inactive phase chronic hepatitis B patients.
Cho YY; Lee JH; Chang Y; Nam JY; Cho H; Lee DH; Cho EJ; Lee DH; Yu SJ; Lee JM; Kim YJ; Yoon JH
J Viral Hepat; 2018 Oct; 25(10):1161-1171. PubMed ID: 29741286
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment.
Wong GL; Chan HL; Chan HY; Tse PC; Tse YK; Mak CW; Lee SK; Ip ZM; Lam AT; Iu HW; Leung JM; Wong VW
Gastroenterology; 2013 May; 144(5):933-44. PubMed ID: 23415803
[TBL] [Abstract][Full Text] [Related]
13. Clinical management of chronic hepatitis B infection: results from a registry at a German tertiary referral center.
Demir M; Nigemeier J; Kütting F; Bowe A; Schramm C; Hoffmann V; Waldschmidt D; Goeser T; Steffen HM
Infection; 2015 Apr; 43(2):153-62. PubMed ID: 25701223
[TBL] [Abstract][Full Text] [Related]
14. Single Nucleotide Polymorphisms in STAT3 and STAT4 and Risk of Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Piratanantatavorn K; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(18):8405-10. PubMed ID: 26745093
[TBL] [Abstract][Full Text] [Related]
15. Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma.
Jin YJ; Shim JH; Lee HC; Yoo DJ; Kim KM; Lim YS; Suh DJ
J Gastroenterol Hepatol; 2011 Sep; 26(9):1380-8. PubMed ID: 21884247
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors for risk of hepatocellular carcinoma in immune inactive chronic hepatitis B.
Seo SI; Kim HS; Yang BK; Kang JG; Shin WG; Lee JH; Kim HY; Jang MK
Clin Res Hepatol Gastroenterol; 2020 Oct; 44(5):711-717. PubMed ID: 31959567
[TBL] [Abstract][Full Text] [Related]
17. Association of Single Nucleotide Polymorphism rs1053004 in Signal Transducer and Activator of Transcription 3 (STAT3) with Susceptibility to Hepatocellular Carcinoma in Thai Patients with Chronic Hepatitis B.
Chanthra N; Payungporn S; Chuaypen N; Pinjaroen N; Poovorawan Y; Tangkijvanich P
Asian Pac J Cancer Prev; 2015; 16(12):5069-73. PubMed ID: 26163643
[TBL] [Abstract][Full Text] [Related]
18. Incidence of hepatocellular carcinoma after HBsAg seroclearance in chronic hepatitis B patients: a need for surveillance.
Kim GA; Lee HC; Kim MJ; Ha Y; Park EJ; An J; Lee D; Shim JH; Kim KM; Lim YS
J Hepatol; 2015 May; 62(5):1092-9. PubMed ID: 25445399
[TBL] [Abstract][Full Text] [Related]
19. What can we learn from hepatitis B virus clinical cohorts?
Lin CL; Tseng TC; Kao JH
Liver Int; 2015 Jan; 35 Suppl 1():91-9. PubMed ID: 25529093
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes of chronic hepatitis B virus infection in the era of antiviral therapy in Korea.
Park YH; Kim BK; Kim JK; Kim HC; Kim DY; Park JY; Han KH; Kim SU; Shin SH; Hahn KY; Ahn SH
J Gastroenterol Hepatol; 2014 May; 29(5):1005-11. PubMed ID: 24325579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
